Evidence map›Paper›PMID 31046111›Full record

ArticleJAMA ophthalmology2019

Diffuse Uveal Melanocytic Proliferation With Primary Vitreoretinal Lymphoma.

Ilya Leskov, Alice T Lyon, Lee M Jampol

Open access · greenAbstract readCase Reports
In one paragraph

Article in JAMA ophthalmology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Ilya LeskovDepartment of Ophthalmology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
Alice T LyonDepartment of Ophthalmology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
Lee M JampolDepartment of Ophthalmology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
Northwestern University · USSUNY Downstate Health Sciences University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: Bilateral diffuse uveal melanocytic proliferation is a rare sign of several systemic malignant neoplasms. Observations: A patient presenting with uveal melanocytic proliferation underwent a detailed physical examination and extensive imaging. No systemic malignant neoplasm was found. Chorioretinal biopsy was performed, and its immunohistochemical results revealed the presence of primary vitreoretinal lymphoma. Conclusions and Relevance: This patient's results suggest that diffuse uveal melanocytic proliferation may be associated not just with systemic malignant disease, but also with primary intraocular tumors, in this case a primary vitreoretinal lymphoma.

Indexed as

Cell ProliferationAntimetabolites, AntineoplasticBiomarkers, TumorFemaleFluorescein AngiographyHumansInfusions, IntravenousIntravitreal InjectionsLymphoma, Large B-Cell, DiffuseMelanocytesMethotrexateMiddle AgedNeoplasm ProteinsParaneoplastic Syndromes, OcularRetinal NeoplasmsTomography, Optical CoherenceAntimetabolites, AntineoplasticBiomarkers, TumorMethotrexateNeoplasm Proteins

Identifiers

PMID31046111
PMCPMC6499127
OpenAlexW2943430423

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.